Genetic evidence suggests posttraumatic stress disorder as a subtype of major depressive disorder.
Depression
Genetic variation
Genetics
Molecular genetics
Journal
The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877
Informations de publication
Date de publication:
01 02 2022
01 02 2022
Historique:
received:
10
11
2020
accepted:
22
04
2021
pubmed:
28
4
2021
medline:
29
3
2022
entrez:
27
4
2021
Statut:
ppublish
Résumé
BACKGROUNDMajor depressive disorder (MDD) and posttraumatic stress disorder (PTSD) are highly comorbid and exhibit strong correlations with one another. We aimed to investigate mechanisms of underlying relationships between PTSD and 3 kinds of depressive phenotypes, namely, MDD, depressed affect (DAF), and depression (DEP, including both MDD and the broad definition of depression).METHODSGenetic correlations between PTSD and the depressive phenotypes were tested using linkage disequilibrium score regression. Polygenic overlap analysis was used to estimate shared and trait-specific causal variants across a pair of traits. Causal relationships between PTSD and the depressive phenotypes were investigated using Mendelian randomization. Shared genomic loci between PTSD and MDD were identified using cross-trait meta-analysis.RESULTSGenetic correlations of PTSD with the depressive phenotypes were in the range of 0.71-0.80. The estimated numbers of causal variants were 14,565, 12,965, 10,565, and 4,986 for MDD, DEP, DAF, and PTSD, respectively. In each case, causal variants contributing to PTSD were completely or largely covered by causal variants defining each of the depressive phenotypes. Mendelian randomization analysis indicated that the genetically determined depressive phenotypes confer a causal effect on PTSD (b = 0.21-0.31). Notably, genetically determined PTSD confers a causal effect on DEP (b = 0.14) and DAF (b = 0.15), but not MDD. Cross-trait meta-analysis of MDD and PTSD identified 47 genomic loci, including 29 loci shared between PTSD and MDD.CONCLUSIONEvidence from shared genetics suggests that PTSD is a subtype of MDD. This study provides support to the efforts in reducing diagnostic heterogeneity in psychiatric nosology.FUNDINGThe National Key Research and Development Program of China and the National Natural Science Foundation of China.
Identifiants
pubmed: 33905376
pii: 145942
doi: 10.1172/JCI145942
pmc: PMC8803333
doi:
pii:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Nat Genet. 2016 May;48(5):481-7
pubmed: 27019110
J Affect Disord. 2017 Mar 15;211:118-123
pubmed: 28110158
Science. 2018 Jun 22;360(6395):
pubmed: 29930110
Am J Psychiatry. 2004 Aug;161(8):1390-6
pubmed: 15285964
Nat Commun. 2018 Jan 15;9(1):224
pubmed: 29335400
Clin Genet. 2012 Nov;82(5):499-501
pubmed: 22449245
Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7561-6
pubmed: 10852968
Cell. 2006 Nov 17;127(4):831-46
pubmed: 17110340
J Anxiety Disord. 2007;21(2):211-22
pubmed: 17085011
Clin Psychol Rev. 2014 Mar;34(2):87-98
pubmed: 24486520
J Affect Disord. 2019 Sep 1;256:541-549
pubmed: 31280079
Mol Psychiatry. 2018 Jan;23(1):123-132
pubmed: 28115742
J Neural Transm (Vienna). 2019 Jan;126(1):35-45
pubmed: 30610379
Transl Psychiatry. 2020 Jun 30;10(1):209
pubmed: 32606422
Cell. 2019 Dec 12;179(7):1469-1482.e11
pubmed: 31835028
Hum Genet. 2020 Feb;139(2):185-198
pubmed: 31813014
J Neurosci Res. 2020 Jul;98(7):1322-1334
pubmed: 32128872
Psychol Med. 2017 Oct;47(13):2260-2274
pubmed: 28385165
Science. 2006 Feb 17;311(5763):1008-12
pubmed: 16484497
Neuropsychopharmacology. 2018 Sep;43(10):2146-2153
pubmed: 29728651
Nat Genet. 2015 Mar;47(3):291-5
pubmed: 25642630
Nat Genet. 2015 Nov;47(11):1236-41
pubmed: 26414676
Am J Hum Genet. 2012 May 4;90(5):821-35
pubmed: 22560090
PLoS Med. 2013 Nov;10(11):e1001547
pubmed: 24223526
Nat Genet. 2018 Jul;50(7):920-927
pubmed: 29942085
Nat Genet. 2018 May;50(5):668-681
pubmed: 29700475
Nat Commun. 2017 Nov 14;8(1):1488
pubmed: 29133852
Neuroscience. 2003;117(3):645-58
pubmed: 12617969
PLoS One. 2014 Nov 25;9(11):e113662
pubmed: 25423262
Nat Rev Genet. 2013 Jul;14(7):483-95
pubmed: 23752797
JAMA Psychiatry. 2016 Jul 1;73(7):750-2
pubmed: 27224895
JAMA Psychiatry. 2016 Jul 1;73(7):753-4
pubmed: 27223123
Biol Psychiatry. 2015 Jan 1;77(1):43-51
pubmed: 24951455
World Psychiatry. 2015 Feb;14(1):27-9
pubmed: 25655146
J Anxiety Disord. 2007;21(2):161-3
pubmed: 17049804
Psychiatry Clin Neurosci. 2018 Mar;72(3):160-167
pubmed: 29112298
J Clin Psychiatry. 2008 Apr;69(4):597-602
pubmed: 18294026
J Clin Psychiatry. 2000;61 Suppl 7:22-32
pubmed: 10795606
Int J Epidemiol. 2015 Apr;44(2):512-25
pubmed: 26050253
Science. 2006 Feb 17;311(5763):1012-7
pubmed: 16484498
J Trauma Stress. 2013 Jun;26(3):299-309
pubmed: 23696449
Nat Commun. 2019 Oct 8;10(1):4558
pubmed: 31594949
Elife. 2016 Oct 25;5:
pubmed: 27779093
J Anxiety Disord. 2007;21(2):233-41
pubmed: 17141468
Nat Commun. 2017 Nov 28;8(1):1826
pubmed: 29184056
Sci Rep. 2019 Apr 1;9(1):5457
pubmed: 30932003
Nucleic Acids Res. 2019 Jan 8;47(D1):D1005-D1012
pubmed: 30445434
Nat Commun. 2019 Jun 3;10(1):2417
pubmed: 31160569
Eur J Hum Genet. 2016 Jan;25(1):137-146
pubmed: 27552965
Int J Psychophysiol. 2015 Nov;98(2 Pt 2):365-377
pubmed: 26156938
Nat Neurosci. 2019 Mar;22(3):343-352
pubmed: 30718901
J Biol Chem. 1999 Mar 19;274(12):8224-30
pubmed: 10075727
Lancet. 2018 Nov 10;392(10159):1859-1922
pubmed: 30415748
Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9397-402
pubmed: 18599437
J Trauma Stress. 2010 Oct;23(5):537-52
pubmed: 20839310
Cereb Cortex. 2015 Oct;25(10):3572-85
pubmed: 25209608
Psychosom Med. 2011 Oct;73(8):697-707
pubmed: 21949429